Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1360157
European Journal of Endocrinology, Vol 136, Issue 2, 157-164
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markussis, V.
Right arrow Articles by Johnston, D. G
Right arrow Search for Related Content
PubMed
Right arrow Articles by Markussis, V.
Right arrow Articles by Johnston, D. G

Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults

Viron Markussis, Salem A Beshyah, Charles Fisher, Kim H Parker, Andrew N Nicolaides and Desmond G Johnston

Objective: Although vascular mortality is increased in hypopituitary adults on routine replacement, there are limited data on the atherosclerotic process during life in these patients. Measurement of arterial stiffness may provide an index of early vascular changes that predispose to the development of major vascular accidents.

Design: Thirty-four hypopituitary adults on conventional replacement therapy and 39 age- and sex-matched controls were studied. They had no history or clinical evidence of macrovascular disease. The common carotid artery distensibility coefficient (DC), compliance coefficient (CC) and arterial stiffness index (beta index) were calculated from high-resolution ultrasonic imaging of the two common carotid arteries and from the brachial blood pressure.

Results: There was no difference between patients and controls in carotid diastolic diameter (mean ± S.E.M.) (5·55 ± 0·16 vs 5·45 ± 0·08 mm) and pulse pressure (6·66 ± 0·30 vs 6·58 ± 0·24 kPa). The increase in diameter during systole was significantly lower in the hypopituitary patients (0·39 ± 0·02 vs 0·50 ±0·03 mm, P < 0·001). The DC was significantly lower in patients than in controls (24·2 ± 2·29 vs 30·1 ± 2·01 10–3kPa–1, P < 0·05). The carotid CC was also significantly lower in patients than in controls (5·7 ± 0·49 vs 7·0 ± 0·45 10–7m2kPa–1, P < 0·05). The beta index was higher in the patient group (8·4 ± 1·3 vs 5·9 ± 0·37, P < 0·05). When men and women were considered separately, the differences between patients and controls were statistically significant in women but not in men and were more marked in the older women subgroup.

Conclusions: Asymptomatic hypopituitary adults (especially women) on conventional replacement therapy have increased stiffness of the common carotid arteries. These findings provide additional evidence for a process leading to premature atherosclerosis in this group of patients.

European Journal of Endocrinology 136 157–164




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
F. Sen, M. Demirturk, N. Abaci, E. Golcuk, H. Oflaz, A. Elitok, F. Kutluturk, H. Issever, N. E. Unaltuna, and N. C. Ozbey
Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients
Eur. J. Endocrinol., May 1, 2008; 158(5): 615 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. M. Dekkers, N. R. Biermasz, A. M. Pereira, F. Roelfsema, M. O. van Aken, J. H. C. Voormolen, and J. A. Romijn
Mortality in Patients Treated for Cushing's Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 976 - 981.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Gola, S. Bonadonna, M. Doga, and A. Giustina
Growth Hormone and Cardiovascular Risk Factors
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1864 - 1870.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Hoffman, C. J. Strasburger, A. Zagar, W. F. Blum, A. Kehely, and M. L. Hartman
Efficacy and Tolerability of an Individualized Dosing Regimen for Adult Growth Hormone Replacement Therapy in Comparison with Fixed Body Weight-Based Dosing
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3224 - 3233.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A.F.C. Schut, J.A.M.J.L. Janssen, J. Deinum, J.M. Vergeer, A. Hofman, S.W.J. Lamberts, B.A. Oostra, H.A.P. Pols, J.C.M. Witteman, and C.M. van Duijn
Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension
Stroke, July 1, 2003; 34(7): 1623 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Irving, M. N. Carson, D. J. Webb, and B. R. Walker
Peripheral Vascular Structure and Function in Men with Contrasting GH Levels
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3309 - 3314.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet
Optimizing GH Therapy in Adults and Children
Endocr. Rev., August 1, 2001; 22(4): 425 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Borson-Chazot, A. Serusclat, Y. Kalfallah, X. Ducottet, G. Sassolas, S. Bernard, F. Labrousse, J. Pastene, A. Sassolas, Y. Roux, et al.
Decrease in Carotid Intima-Media Thickness after One Year Growth Hormone (GH) Treatment in Adults with GH Deficiency
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1329 - 1333.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Pfeifer, R. Verhovec, B. Zizek, J. Prezelj, P. Poredos, and R. N. Clayton
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 453 - 457.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.